Combination botensilimab plus balstilimab demonstrates promising activity in heavily pre-treated MSS CRC Presented ByProf. Anthony El-Khoueiry, Norris Comprehensive Cancer Center, CA, USA TrialPhase 1, C-800 ConferenceASCO GI 2023 17 March, 2023 09:06